20261890: Vertex Pharmaceuticals Incorporated; Crinetics Pharmaceuticals, Inc.

Дата публикации: 14-08-2026 18:07:49

20261890: Vertex Pharmaceuticals Incorporated; Crinetics Pharmaceuticals, Inc.
Date

August 12, 2026

bacree
August 14, 2026 | 2:07PM
Transaction Number

20261890

Acquiring Party

Vertex Pharmaceuticals Incorporated

Acquired Party

Crinetics Pharmaceuticals, Inc.

Granting Status

Granted

Acquired Entities

Crinetics Pharmaceuticals, Inc.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	20261873: Novartis AG; Myricx Pharma Limited	0	6.07	05-08-2026
2	20261888: Solstice Advanced Materials Inc.; Element Solutions Inc	0	5.73	14-08-2026
3	20261902: Bridgepoint Group plc; Kayne Anderson Capital Advisors, L.P.	0	5.9	14-08-2026
4	20261901: Bridgepoint Group plc; Albert Rabil III	0	6.07	14-08-2026
5	20261904: Invidia Bright Topco LP; Massimo Musa	0	6.07	14-08-2026
6	20261875: ON Semiconductor Corporation; Synaptics Incorporated	0	6.07	14-08-2026
7	20261916: H2O America; Quadvest, L.P.	0	6.07	14-08-2026
8	20261868: GTCR Fund XIV/B LP; Reveal Holdco, LLC	0	6.07	14-08-2026
9	20261932: Audax Private Equity Fund IV CF, L.P.; American Pacific Group Fund II, L.P.	0	5.9	14-08-2026
10	20261869: GIP Mid-Market Fund V B-2, SCSp; Summit Ridge Energy, LLC	0	7.6	14-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.9. Источник: www.ftc.gov.